posted on 2021-04-19, 19:56authored byYou-jung Choi, Kyung-Do Han, Eue-Keun Choi, Jin-Hyeung Jung, So-Ryoung Lee, Seil Oh, Gregory Y. H. Lip
<b>Objectives:</b> To investigate the effects of alcohol abstinence in preventing
new-onset atrial fibrillation (AF) in patients with type 2 diabetes mellitus
(T2DM).
<p><b>Research Design and Methods:</b> A total of 1,112,682 patients newly
diagnosed with T2DM between 2011–2014, were identified from the Korean National
Health Insurance Service database. After excluding a previous history of AF,
175,100 subjects were included. The primary outcome was new-onset AF.</p>
<p><b>Results:</b>
During a mean follow-up of 4.0 years, AF occurred in 4,174 patients. Heavy alcohol consumption
(alcohol intake ≥40
g/day) before
a T2DM diagnosis had a higher risk of AF (adjusted hazard ratio [aHR] 1.22, 95%
confidence interval [CI] 1.06–1.41) compared to no alcohol consumption. After a
T2DM diagnosis, moderate-to-heavy alcohol consumption (alcohol
intake ≥20 g/day) who abstained from alcohol had a lower risk
of AF (aHR 0.81, 95% CI 0.68–0.97) than did constant drinkers. Alcohol
abstinence showed consistent trends toward lower incident AF in all subgroups
and was statistically significant in men (aHR 0.80, 95% CI 0.67–0.96),
those aged >65 years (aHR 0.69, 95% CI 0.52–0.91), those with CHA<sub>2</sub>DS<sub>2</sub>-VASc
score <3 points (aHR
0.71, 95% CI 0.59–0.86), non-insulin users (aHR 0.77, 95% CI 0.63–0.94), and body mass
index < 25 mg/k<sup>2</sup> (aHR 0.68, 95% CI 0.53–0.88).</p>
<p><b>Conclusions</b>: In patients with newly diagnosed T2DM, alcohol abstinence was
associated with a low risk of AF development. Lifestyle modifications, such as
alcohol abstinence, in patients newly diagnosed with T2DM should be recommended
to reduce the risk of AF.</p>
Funding
This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, the Ministry of Food and Drug Safety) (Project Number: 202013B14), and by the Korea National Research Foundation funded by the Ministry of Education, Science and Technology (grant 2020R1F1A106740).